Current position:Home >Product >
butyl 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate
butyl 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate(2227199-31-5)
- Name: butyl 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate
- Synonyms:2227199-31-5;EXA92262Y4;Tofacitinib n-butyl 3-oxopropanoate;butyl 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate;Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;BUTYL 3-[(3R,4R)-4-METHYL-3-[METHYL({7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PIPERIDIN-1-YL]-3-OXOPROPANOATE;butyl 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate;butyl3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate;UNII-EXA92262Y4;CS-0166089;P18068;1-PIPERIDINEPROPANOIC ACID, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, BUTYL ESTER, (3R,4R)-;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-, butyl ester, (3R,4R)-;butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate? (Tofacitinib Impurity;BUTYL3-[(3R,4R)-4-METHYL-3-[METHYL({7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PIPERIDIN-1-YL]-3-OXOPROPANOATE
- Molecular Formula:C20H29N5O3
- Molecular Weight:387.5
- CAS Registry Number:2227199-31-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1269292-72-9/6-Amino-2-(trifluoromethyl)pyrimidine-4-carboxylic acid
- 1338494-94-2/2-(2-Methoxyethoxy)-4-methyl-1,3-thiazole-5-carboxylic acid
- 948291-31-4/8-Ethyl-2-methylquinoline-3-carboxylic acid
- 59495-80-6/Iron(2+) 2,9-dioxotricyclo[10.2.1.1~5,8~]hexadeca-5(16),6,12(15),13-tetraene-1,8-diide
- 1193388-39-4/(8-Methyl-8-azabicyclo[3.2.1]octan-3-YL)methanamine dihydrochloride
- 1261976-67-3/5-(3-Cyano-2-fluorophenyl)-2-hydroxynicotinic acid
- 1310405-08-3/(3-Amino-5-ethoxypyridin-4-yl)boronic acid
- 1956330-88-3/7-Chloro-4-(cyclopentyloxy)-1,6-naphthyridine
- 324560-66-9/2,2,2-trifluoro-N-[3-(hydroxymethyl)phenyl]acetamide
- 335621-31-3/3-(Ethylsulfonyl)propyl 4-methylbenzenesulfonate
- 1638760-51-6/{5-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanol
- 886361-69-9/2-Fluoro-4-(3-thienyl)benzenecarbonitrile
- 64047-43-4/(1S)-(-)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride
- 77740-26-2/Diethyl 13-acetyl-1,10-diazapentacyclo[7.6.0.02,7.010,12.013,15]pentadeca-2,4,6,8-tetraene-8,15-dicarboxylate
- 893740-53-9/5-(4-(Methylsulfonyl)phenyl)nicotinic acid
- 273207-02-6/4-Ethylpiperazine-1-sulfonyl chloride
- 1261929-09-2/3-(3-Chlorophenyl)-5-fluorobenzoic acid
- 1290176-71-4/5,7-Dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
- 30223-88-2/N-[(4-benzo[a]anthracen-7-ylphenyl)methyl]-2-chloro-N-methylethanamine;hydrochloride
- 2227199-31-5/butyl 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanoate
- 721924-06-7/N3-Methyl pantoprazole
- 1621679-06-8/Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-amino-6-bromo-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-
- 116050-35-2/N,N-Didesmethyl Diltiazem Hydrochloride
- 1420792-10-4/2-(1H-Imidazol-2-yl)morpholine
- 1221792-04-6/5-(4-bromo-3-fluorophenyl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
- 340828-48-0/2-Fluorobenzyl 4-amino-1,2,5-oxadiazole-3-carboxylate
- 66171-75-3/Alaproclate, (S)-
- 1422365-93-2/Unii-4G3buv6zsk
- 23384-48-7/3-(4-Chlorophenyl)[1,3]thiazolo[2,3-b][1,3]benzothiazol-4-ium perchlorate
- 1346708-05-1/2-((4-Fluorobenzyl)oxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine